Bio Solution Co.,Ltd. (KOSDAQ:086820)
7,100.00
+80.00 (1.14%)
At close: Jun 11, 2026
Bio Solution Market Cap
Bio Solution has a market cap or net worth of 183.21 billion as of June 12, 2026. Its market cap has decreased by -31.60% in one year.
Market Cap
183.21B
Enterprise Value
191.48B
Revenue
15.82B
Ranking
n/a
PE Ratio
262.86
Stock Price
7,100.00
Market Cap Chart
Since August 20, 2018, Bio Solution's market cap has decreased from 218.31B to 183.21B, a decrease of -16.08%. That is a compound annual growth rate of -2.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 183.21B | -4.18% |
| Dec 30, 2025 | 191.20B | 10.84% |
| Dec 30, 2024 | 172.51B | 10.88% |
| Dec 28, 2023 | 155.58B | 82.92% |
| Dec 29, 2022 | 85.05B | -50.94% |
| Dec 30, 2021 | 173.35B | -26.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genome & Company | 259.75B |
| Kanaph Therapeutics | 249.42B |
| curacle co.,ltd. | 243.72B |
| Kangstem Biotech | 232.31B |
| NIBEC | 208.03B |
| ViGenCell | 201.51B |
| Y-Biologics | 198.83B |
| Ensol Biosciences | 171.49B |